Dr. Miguel De Jesus Rodriguez, MD

Dr. Rodriguez practices at Baptist Health Endoscopy Center at Galloway North in Miami, Florida.

Dr. Rodriguez's NPI, 1205815529, was assigned on January 13, 2006. Dr. Rodriguez graduated from Universidad Nacional Pedro Henriquez Urena in 1983. Dr. Rodriguez holds Florida license ME68746.

Dr. Rodriguez's primary practice is Baptist Health Endoscopy Center at Galloway North, at 7500 Sw 87th Ave, Suite 101, Miami, FL 33173. The practice phone is (305) 595-9511.

Dr. Rodriguez's primary practice is Baptist Health Endoscopy Center at Galloway North in Miami, Florida. Dr. Rodriguez is also affiliated with Baptist Health Baptist Hospital. The medical group on file is Miami Gastroenterology Consultants. Dmand AI also links Dr. Rodriguez to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rodriguez practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Rodriguez's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Rodriguez is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Rodriguez is licensed in Florida.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), colonoscopy, fatty liver, gastroduodenitis and gastroenteritis among the conditions Dr. Rodriguez treats.

CMS data shows 916 Medicare services from Dr. Rodriguez across 11 procedure codes in 2024, for 300 Medicare patients. Medicare paid $87,587 for them.

CMS counts 300 Medicare patients who saw Dr. Rodriguez in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 57% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rodriguez's median patient age at 63, with 60% women.

In 2024, Dr. Rodriguez wrote 3,772 Medicare Part D claims for 773 patients. 77% of them were for generic drugs. CMS names the drug for 3,487 of them, across 44 drugs with 11 or more claims each, at $1,234,911 in total drug cost. In 2023, CMS named 3,617 claims across 42 drugs.

Dr. Rodriguez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rodriguez as offering telehealth. CMS counts 124 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Rodriguez, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Rodriguez in 2020. Dr. Rodriguez's most frequent co-authors are Catherine Therese Frenette, MD and Edward Alfonso Mena, MD.

Dmand AI links Dr. Rodriguez to 3 clinical trials. Conditions studied include Colitis, Ulcerative, Colitis and Crohn Disease. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Rodriguez that name 3 trials.

CMS Open Payments shows 79 general payments to Dr. Rodriguez from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 54% of the total. Gilead Sciences, Inc. paid the most, $1,636. It also lists 7 research payments totaling $20,848 from 2018 to 2022, naming 3 clinical trials.

Dmand AI lists 1 award for Dr. Rodriguez, most recently CMS Stage 1 2012 in 2012.

Dr. Rodriguez graduated from Universidad Nacional Pedro Henriquez Urena in 1983. Dr. Rodriguez is a member of ACG and FMA.

Dr. Rodriguez is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.